NextCure downgraded to underperform from neutral at BofA Securities

1 BUSINESS

Business News - Opportunities - Reviews

 

 

NextCure Inc.

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply